H. Lundbeck A/S
2 clinical trials · 2 recruiting · INDUSTRY
Trials by H. Lundbeck A/S
RECRUITINGPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Sponsor: H. Lundbeck A/SEnrolling: 28520 locations
Chronic Migraine in Children
RECRUITINGPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
Sponsor: H. Lundbeck A/SEnrolling: 60020 locations
Migraine